Entry |
|
Symbol |
CYP2C19
|
Name |
|
Pathway |
map00982 | Drug metabolism - cytochrome P450 |
map05204 | Chemical carcinogenesis - DNA adducts |
|
Reaction |
|
Disease |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09100 Metabolism
09103 Lipid metabolism
00590 Arachidonic acid metabolism
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
00591 Linoleic acid metabolism
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
09111 Xenobiotics biodegradation and metabolism
00982 Drug metabolism - cytochrome P450
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
09150 Organismal Systems
09156 Nervous system
04726 Serotonergic synapse
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
09160 Human Diseases
09161 Cancer: overview
05204 Chemical carcinogenesis - DNA adducts
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
09180 Brite Hierarchies
09181 Protein families: metabolism
00199 Cytochrome P450
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
Enzymes [BR:ko01000]
1. Oxidoreductases
1.14 Acting on paired donors, with incorporation or reduction of molecular oxygen
1.14.14 With reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen into the other donor
1.14.14.51 (S)-limonene 6-monooxygenase
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
1.14.14.52 (S)-limonene 7-monooxygenase
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
1.14.14.53 (R)-limonene 6-monooxygenase
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
1.14.14.75 fenbendazole monooxygenase (4'-hydroxylating)
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
Cytochrome P450 [BR:ko00199]
Cytochrome P450, animal type
CYP2 family
K17721 CYP2C19; cytochrome P450 family 2 subfamily C19
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA |
Title |
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. |
Journal |
|
Sequence |
|